NOF PRESENTS at AAPS 2020 PharmaSci 360 -VIRTUAL-
NOF CORPORATION will present NOF DDS technology for Nucleic Acids Therapeutics and Vaccines at AAPS 2020 PharmaSci 360 -VIRTUAL- held during the period from October 26 to November 5, 2020.
Conference Website: https://www.aaps.org/pharmsci/annual-meeting
We will make two poster presentations about our SS-cleavable and pH-responsive lipids for nucleic acids and gene deliveries as follows. The posters will remain available to registrants until December 31, 2020.
Presentation Title 01:
Self-Adjuvating Lipid Nanoparticle mRNA Vaccine Elicits T-Cell Responses and Protects Against Immune Challenge
*This poster was selected as a winner of the Best Abstract Award and the Rapid Fire Presentation will be made at 4:15 pm on Monday, November 2 in “Discovery and Basic Research” track.
Presentation Title 02:
Safety and In Vivo Gene Delivery Efficiency of COATSOME® SS-Lipids, a Lipid Nanoparticle Platform Composed of Biodegradable Ionizable Lipids
Please contact to our regional offices below for the detail of the presentations or if you have any questions for the contents of the presentations.
NOF AMERICA CORPORATION
Tel: NY Office: +1-914-681-9790
CA Office: +1-650-993-7375
[Asia Pacific, Japan] NOF CORPORATION DDS Development Division
NOF EUROPE GmbH
NOF (Shanghai) Co. Ltd.
No posts found